Get the app
US › Healthcare

Propanc Biopharma, Inc. Common Stock (PPCB)

US · Healthcare · Biotechnology

$1.77+7.93%
Last close · 2026-11-06

Key statistics

Market cap
$1.7M
Forward P/E
0.0
P/B
0.17
Book value
$28.40
EPS (TTM)
$-176.20
52-week high
$315.00
52-week low
$1.63
50-day MA
$5.97
200-day MA
$21.93
Beta
3.33

Analyst view

with an average price target of $1.52.

Shareholding

Insiders
38.12%
Institutions
0.57%

Largest institutional holders

FundStake
Jane Street Group LLC0.26%
Citadel Advisors Llc0.12%
HRT FINANCIAL LLC0.10%
Caitong International Asset Management Co., Limited.0.00%
Mercer Global Advisors Inc.0.00%
Sassicaia Capital Advisers LLC0.00%
XTX Topco Ltd0.00%
Marex Group Ltd0.00%

Corporate actions

ActionDetailDate
Split1 : 10
effective Oct 26, 2026		2026-10-26

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Propanc Biopharma, Inc. Common Stock — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-11-07.